Prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos, Nigeria

Introduction The study was carried out to determine the prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos. Method A cross-sectional study conducted to determine the prevalence and risk factors for hepatitis B and C viral co-infection in children aged 2 months to 13 years. There were 187 HIV infected and 187 HIV naïve age, sex-matched controls. Blood samples of participants were assayed for the serologic markers [HBsAg, anti-HBc, and anti-HCV)] of HBV and HCV viral infections using the Enzyme-Linked Immunosorbent assay (ELISA) method. Result The prevalence of HBV infection using HBsAg was 5.3% and 4.8% (p = 0.814), among HIV-infected and HIV naïve children respectively, while using anti-HBc the prevalence was 7.0% and 7.5% (p = 0.842) among HIV- infected and HIV naïve children respectively. The prevalence of HCV infection among HIV- infected and HIV naive children were equal to 0.5% (p = 1.000). There was also no significant association with the identifiable risk factors (sharing of a toothbrush, sharing of needles, incision marks/tattoo, hepatitis B immunization status, history of blood transfusion, previous surgical operation, sexual exposure/abuse, history of jaundice, and genital circumcision) and the HBV and or HCV status among both groups of children. History of sexual exposure/abuse and history of jaundice were however found to be predictors of the presence of HBsAg among HIV infected children only, using a binary logistic regression model. Conclusion The prevalence of HBV and or HCV infection among HIV-infected children is similar to the prevalence among HIV naïve children, suggesting that HIV-infected children are not more predisposed to viral hepatitis than healthy children. Also, there was no significant difference in the prevalence of HBV infection irrespective of the use of HBsAg or anti-HBc.

[1]  S. Hutchinson,et al.  The seroprevalence of hepatitis C virus infection among children and their mothers attending for dental care in Glasgow, Scotland, United Kingdom. , 2017, Journal of infection and public health.

[2]  O. Ejiofor,et al.  Seroprevalence of HBV and HIV Co-infection in Children in Nnewi, South-East, Nigeria , 2017 .

[3]  B. Ibe,et al.  Risk factors for hepatitis B surface antigenaemia among secondary school students in Abakaliki, South Eastern Nigeria , 2017 .

[4]  R. Parboosing,et al.  The prevalence of hepatitis B virus infection in HIV-positive and HIV-negative infants: KwaZulu-Natal, South Africa , 2016, African journal of laboratory medicine.

[5]  E. Udoh,et al.  The prevalence of hepatitis B virus infection in Nigerian children prior to vaccine introduction into the National Programme on Immunization schedule , 2016, The Pan African medical journal.

[6]  A. Ikefuna,et al.  Seroprevalence and Risk Factors of Hepatitis B Virus Infection among Adolescents in Enugu, Nigeria. , 2015, Journal of tropical pediatrics.

[7]  Joshua Awoleye Olatunji,et al.  Determinants of human immunodeficiency virus (HIV) infection in Nigeria: A synthesis of the literature , 2015 .

[8]  R. Newton,et al.  Prevalence of hepatitis C virus in mothers and their children in Malawi , 2015, Tropical medicine & international health : TM & IH.

[9]  S. Eholie,et al.  Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. , 2015, Journal of hepatology.

[10]  M. A. Isa,et al.  Prevalence of Hepatitis B virus infection among children attending mohammed shuwa memorial hospital Maiduguri, Borno state, Nigeria , 2015 .

[11]  N. Uleanya,et al.  Prevalence and risk factors of hepatitis B virus transmission among children in Enugu, Nigeria , 2015 .

[12]  P. Sogni,et al.  Hepatitis B and human immunodeficiency virus co-infection. , 2014, World journal of gastroenterology.

[13]  M. Kibret,et al.  Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the felgehiwot referral hospital, Ethiopia , 2014, BMC Research Notes.

[14]  S. Teles,et al.  Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil , 2014, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[15]  J. Goss,et al.  Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. , 2014, World journal of gastroenterology.

[16]  M. Law,et al.  A New Method for Assessing How Sensitivity and Specificity of Linkage Studies Affects Estimation , 2014, PloS one.

[17]  M. Daw,et al.  Seroprevalence of HBV, HCV & HIV Co-Infection and Risk Factors Analysis in Tripoli-Libya , 2014, PloS one.

[18]  A. Ofili,et al.  Hepatitis B infection among Nigerian children admitted to a children's emergency room. , 2014, African health sciences.

[19]  H. Hakimi,et al.  Prevalence of Hepatitis B Co-Infection among HIV Positive Patients: Narrative Review Article , 2014, Iranian journal of public health.

[20]  Khakshour Ali,et al.  Key Facts about Epidemiology of HIV/AIDS in Children Worldwide , 2014 .

[21]  K. Fasakin,et al.  Sero-Prevalence of Hepatitis B and Hepatitis C Virue Co-Infection among Pregnant Women in Nigeria , 2014 .

[22]  P. Kanki,et al.  Prevalence and Laboratory Profile of Hepatitis B Virus Co-infected Nigerian Children with Human Immunodeficiency Virus , 2014 .

[23]  S. Ernest,et al.  Prevalence of HIV co-infection with Hepatitis B and C viruses among children at a tertiary hospital in Ilorin , Nigeria , 2014 .

[24]  A. Ebonyi,et al.  Human immunodeficiency virus and Hepatitis C virus co-infection in children in Jos, Nigeria , 2014 .

[25]  E. Ikpeme,et al.  Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South Nigeria. , 2014, African health sciences.

[26]  A. Nyamache,et al.  Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya , 2013, BMC Research Notes.

[27]  J. Mawak,et al.  Prevalence and immune status of HIV/HBV co-infected pregnant women , 2013 .

[28]  A. Habib,et al.  Prevalence of hepatitis B and C virus infections among HIV-infected patients in a tertiary hospital in North-Western Nigeria , 2013 .

[29]  Ayodotun Olutola,et al.  Prevalence and Clinical and Immunoviralogical Profile of Human Immunodeficiency Virus-Hepatitis B Coinfection among Children in an Antiretroviral Therapy Programme in Benue State, Nigeria , 2013, ISRN pediatrics.

[30]  Tamoghna Biswas,et al.  How to Calculate Sample Size for Different Study Designs in Medical Research? , 2013, Indian journal of psychological medicine.

[31]  E. Nwolisa,et al.  Prevalence of Hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-eastern Nigeria , 2013, The Pan African medical journal.

[32]  E. Sokal,et al.  Chronic hepatitis B in children and adolescents. , 2012, Journal of hepatology.

[33]  T. M. Balogun,et al.  HIV, Hepatitis B and C viruses’ coinfection among patients in a Nigerian tertiary hospital , 2012, The Pan African medical journal.

[34]  Jia‐Feng Wu,et al.  Viral hepatitis in children. , 2012, Journal of pediatric gastroenterology and nutrition.

[35]  Gretchen A. Stevens,et al.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.

[36]  P. Okerentugba,et al.  Detection Of Hepatitis B Surface Antigen (HBsAg) Among Children In Ibadan, Southwestern Nigeria , 2012 .

[37]  F. Meurice,et al.  Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria , 2011, Human vaccines.

[38]  W. Sadoh,et al.  HIV co-infection with hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme , 2011 .

[39]  J. Njab,et al.  Hepatitis C Virus Co-Infection In Human Immuno Deficiency Virus Positive Population In Bida, North Central Nigeria. , 2010 .

[40]  Shuntai Zhou,et al.  Hepatitis B and Hepatitis C Seroprevalence in Children Receiving Antiretroviral Therapy for Human Immunodeficiency Virus-1 Infection in China, 2005-2009 , 2009, Journal of acquired immune deficiency syndromes.

[41]  H. Abubakar,et al.  Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection. , 2010, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria.

[42]  E. Ugwuja,et al.  Seroprevalence of Hepatitis B Surface Antigen and Liver Function Tests among Adolescents in Abakaliki, South Eastern Nigeria , 2009 .

[43]  Edward Mills,et al.  Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[44]  G. Bazuaye,et al.  Hepatitis C Virus and Human Immunodeficiency Virus-I (HIV) Co-Infection in Children in Benin City, Nigeria. , 2011 .

[45]  C. Rouzioux,et al.  Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  G. Carosi,et al.  Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  M. Matee,et al.  Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania , 2007, BMC public health.

[48]  M. Rosenberg,et al.  Prevalence of hepatitis B and C virus infections in children infected with HIV. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  William C. Grant,et al.  The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. , 2006, The Journal of pediatrics.

[50]  R. Oberhelman Traveler's Vaccines, Elaine C. Jong, Jane N. Zuckerman. BC Decker Inc, Hamilton, Ontario, Canada (2004), 550 pages, ISBN: 1-550099-225-1 (US$104.95) , 2005 .

[51]  J. Lindsey,et al.  Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. , 2004, Archives of pediatrics & adolescent medicine.

[52]  Man-Fung Yuen,et al.  Viral hepatitis B , 2003, The Lancet.

[53]  P. Klenerman,et al.  Viral coinfections among African children infected with human immunodeficiency virus type 1. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  T. Harrison,et al.  Genotypes of hepatitis C virus in Nigeria , 1996, Journal of medical virology.

[55]  W P Havens,et al.  Viral hepatitis. , 1970, The Medical clinics of North America.